FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to veterinary. Medication contains water-salt solution, including 45-50%-"Haemodez-N" and 0.125-1.0% magnesium sulfate heptahydrate, 0.08% endonuclease of bacteria Serratia marcesecens in 1% water solution of sodium chloride, "Haemodez-N", magnesium sulfate and bacterial endonuclease being taken in ratio 1:1:2, respectively.
EFFECT: easy producing and antitoxic effect.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF USING Bacillus intermedius RIBONUCLEASE | 2012 |
|
RU2509801C2 |
| PHARMACEUTICAL COMPOSITION FOR IMPROVING RHEOLOGICAL PROPERTIES OF SPUTUM BASED ON ENZYME NUCLEASE SERRATIA MARCESCENS | 2018 |
|
RU2695132C1 |
| ANTIRABIC INACTIVATED EMULSION CULTURE VACCINE FOR PROPHYLACTIC IMMUNIZATION OF DOMESTIC CARNIVORES AND FARM ANIMALS | 2019 |
|
RU2722868C1 |
| PHARMACEUTICAL COMPOSITION FOR PASSIVE RABIES IMMUNIZATION, PHARMACEUTICAL KIT, PHARMACEUTICAL KIT APPLICATION METHOD | 2016 |
|
RU2661028C2 |
| METHOD OF PRODUCTION OF RABIES DIAGNOSTIC SERUM | 2015 |
|
RU2609766C1 |
| TRIMERISED SINGLE-DOMAIN ANTIBODY THAT SPECIFICALLY BINDS WITH GLYCOPROTEIN G OF RABIES VIRUS, NEUTRALISING RABIES VIRUS | 2013 |
|
RU2533802C1 |
| PREPARATION OF HETEROLOGOUS ANTIRABIC IMMUNOGLOBULIN FOR INTRAVENOUS BOTH INTRAMUSCULAR INTRODUCTION AND METHOD FOR ITS OBTAINING | 2006 |
|
RU2339401C2 |
| GENETIC CONSTRUCT BASED ON AN OPTIMIZED GENE OF RABIES VIRUS CONSENSUS GLYCOPROTEIN FOR PREVENTING RABIES | 2018 |
|
RU2707544C1 |
| METHOD FOR THE INDIRECT DETERMINATION OF THE CONCENTRATION OF THE IMMUNOGENIC RNP COMPLEX OF RABIES VIRUS IN RAW MATERIALS FOR RABIES VACCINES BY AMPLIFICATION AND HYBRIDIZATION-FLUORESCENT DETECTION OF DNA AMPLICONS | 2020 |
|
RU2760436C1 |
| ENA-21/13-13-FINITE MONOLAYER-SUSPENSION CELL SUBLINE OF KIDNEY OF NEW-BORN SYRIAN HAMSTER, INTENDED FOR REPRODUCTION OF FOOT-AND-MOUTH DISEASE VIRUS AND RABIES VIRUS | 2014 |
|
RU2553552C1 |
